Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.6.3 is now shown, replacing Revision: v3.6.2 in the page footer. This indicates a routine update to the history-view interface of the study record.SummaryDifference0.0%

- Check16 days agoChange DetectedThe Revision tag on the History page was updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the page’s versioning rather than substantive changes to trial content.SummaryDifference0.0%

- Check23 days agoChange DetectedA new history entry dated 2026-06-17 adds Contacts/Locations and Study Status sections to the record. This also includes a related 2026-06-16 entry and a numeric value 100, indicating updates to the study history data.SummaryDifference0.2%

- Check30 days agoChange DetectedThe history now includes 'No longer looking for participants', indicating recruitment has ended. The record updates to Revision: v3.6.0, replacing Revision: v3.5.5 in the history.SummaryDifference0.2%

- Check37 days agoChange DetectedThe Record History now shows Revision: v3.5.5, replacing the prior v3.5.4. This reflects a small update to the page's version rather than changes to trial information.SummaryDifference0.0%

- Check59 days agoChange DetectedThe record history now includes a new revision entry, v3.5.4, while the previous v3.5.3 entry is removed from the list.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.